Your browser doesn't support javascript.
loading
Severe acute respiratory syndrome coronavirus 2 escape mutants and protective immunity from natural infections or immunizations.
Di Caro, Antonino; Cunha, Flavia; Petrosillo, Nicola; Beeching, Nicholas J; Ergonul, Oner; Petersen, Eskild; Koopmans, Marion P G.
Afiliación
  • Di Caro A; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Laboratory of Microbiology, National Institute for Infectious Diseases 'Lazzaro Spallanzani', Rome, Italy; Department of Molecular Medicine, San Matteo Hospital, U
  • Cunha F; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Department of Infectious Diseases, Coimbra Hospital and University Centre, Coimbra, Portugal.
  • Petrosillo N; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), International Affairs Subcommittee, Basel, Switzerland; Clinical and Research Department, National Institute for Infectious Diseases 'Lazzaro Pallanzani', Rome, Italy.
  • Beeching NJ; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Tropical and Infectious Disease Unit, Royal Liverpool University Hospital, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Ergonul O; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Koç University Research Centre for Infectious Diseases, Istanbul, Turkey.
  • Petersen E; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark. Electronic address: eskild.petersen@gmail.com.
  • Koopmans MPG; European Society for Clinical Microbiology and Infectious Diseases (ESCMID), Emerging Infections Task Force, ESCMID, Basel, Switzerland; Viroscience Department, ErasmusMC, WHO Collaborating Centre, Rotterdam, the Netherlands.
Clin Microbiol Infect ; 27(6): 823-826, 2021 06.
Article en En | MEDLINE | ID: mdl-33794345

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunación / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Mutación Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunación / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Mutación Límite: Humans Idioma: En Revista: Clin Microbiol Infect Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2021 Tipo del documento: Article